DTx Pharma Appoints Peter Condon as Chief Business Officer

2022-09-26T06:02:40-07:00June 28th, 2022|

San Diego – June 28, 2022 – DTx Pharma, Inc. (DTx), a privately-held biotechnology company developing novel RNA-based therapeutics to treat the genetic drivers of [...]